|
OMRIX currently manufactures and develops products in two areas: biosurgery and passive immunotherapy. While the end users are very different in these two areas of specialty, we develop and commercialize all products through the use of our proprietary protein purification technology and manufacturing know-how.
Our proprietary protein purification technology is designed to purify proteins from plasma while maintaining their natural structure to preserve their full range of biological activities. We can employ this technology on a commercial scale to either isolate proteins of interest or remove unwanted proteins from raw materials such as human plasma or plasma fractions.
|